Cargando…
Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
Autores principales: | Zhao, Fei, Evans, Kathy, Holtzhausen, Alisha, Orabona, Ciriana, Hanks, Brent A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292429/ http://dx.doi.org/10.1186/2051-1426-2-S3-P209 |
Ejemplares similares
-
Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy
por: Holtzhausen, Alisha, et al.
Publicado: (2014) -
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8(+) Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)
por: Pallotta, Maria T., et al.
Publicado: (2010) -
Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization
por: Holtzhausen, Alisha, et al.
Publicado: (2013) -
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
por: Coletti, Alice, et al.
Publicado: (2017) -
Indoleamine 2,3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme
por: Pallotta, Maria Teresa, et al.
Publicado: (2021)